DexCom

YTD

ALL

Trade DexCom 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About DXCM

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE.

CEO

Jacob S. Leach

CEOJacob S. Leach

Employees

10,300

Employees10,300

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

1999

Founded1999

Employees

10,300

Employees10,300

DXCM Key Statistics

Market cap

29.72B

Market cap29.72B

Price-Earnings ratio

53.51

Price-Earnings ratio53.51

Dividend yield

—

Dividend yield—

Average volume

4.84M

Average volume4.84M

High today

$77.22

High today$77.22

Low today

$71.80

Low today$71.80

Open price

$72.90

Open price$72.90

Volume

9.24M

Volume9.24M

52 Week high

$93.25

52 Week high$93.25

52 Week low

$57.52

52 Week low$57.52

DXCM News

TipRanks 11h

Dexcom’s Resilience: Addressing G7 Concerns and Achieving 2025 Targets

Josh Jennings, an analyst from TD Cowen, maintained the Buy rating on Dexcom. The associated price target remains the same with $100.00. Elevate Your Investing...

Seeking Alpha 16h

DexCom falls after short report from Hunterbrook

Healthcare On the Move DexCom falls after short report from Hunterbrook Sep. 18, 2025 9:47 AM ET DexCom, Inc. (DXCM) Stock By: Joshua Fineman, SA News Editor 5...

TipRanks 3d

Dexcom CEO Takes Medical Leave, Interim Roles Announced

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

Analyst ratings

80%

of 30 ratings

Buy

80%

Hold

20%

Sell

More DXCM News

Simply Wall St 5d

Is DexCom Set for Growth After Recent Share Price Drop in 2025?

Are you wondering what to make of DexCom’s stock these days? You are definitely not alone. Investors have watched DexCom move through a string of changes, with...

People also own

Based on the portfolios of people who own DXCM. This list is generated using Robinhood data, and it’s not a recommendation.